Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normalizing hematocrit in dialysis patients improves brain function.

J L Pickett1, D C Theberge, W S Brown

  • 1Department of Psychiatry and Biobehavioral Science, University of California at Los Angeles, Pasadena, CA, USA.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|June 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to "Disparities in provision of transplant information affect access to kidney transplantation" by Kucirka et al.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Variations of the individual blood plasma amino acid nitrogen level.

The Journal of biological chemistry·2010
Same author

Comfortable effort level in young children's speech.

Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP)·2007
Same author

The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?

Kidney international·2007

Raising hematocrit (Hct) levels in dialysis patients with recombinant human erythropoietin (rHuEPO) improves cognitive function. Achieving normal Hct levels enhances attention and memory, suggesting anemia correction benefits brain health.

Area of Science:

  • Nephrology
  • Neuroscience
  • Hematology

Background:

  • Recombinant human erythropoietin (rHuEPO) improves cognitive function in anemic dialysis patients.
  • Optimal target hematocrit (Hct) for rHuEPO therapy remains debated.
  • Current dialysis patient Hct averages 31-32%, below normal levels.

Purpose of the Study:

  • To evaluate the neurocognitive effects of increasing Hct to normal levels (40-45%) in dialysis patients.
  • To compare cognitive function at current practice Hct versus normal Hct.

Main Methods:

  • Twenty end-stage renal disease (ESRD) patients on rHuEPO (mean Hct 31.6%) received increased rHuEPO to achieve normal Hct (mean 42.8%).
  • Electroencephalogram (EEG) frequency analysis was performed.
  • Neurocognitive testing included auditory oddball and Continuous Performance Task.

Related Experiment Videos

Main Results:

  • EEG showed decreased slowing at higher Hct.
  • P300 amplitude showed significant effects in auditory oddball and Continuous Performance tasks.
  • P300 latency changes correlated with increased Hct in the auditory oddball task.

Conclusions:

  • Anemia correction to normal Hct levels improves neurocognitive function in dialysis patients.
  • Higher Hct enhances attention and memory capabilities.
  • Optimizing Hct may lead to greater cognitive benefits in ESRD patients.